Both in Pharmaceuticals
PMGC Holdings vs Propanc Biopharma
Over the past year ELAB returned −99.8% and PPCB returned −99.4%; their daily moves had a correlation of 0.04.
ELAB −99.8% PPCB −99.4%Growth of $1, one year, split-adjusted
| Metric | ELAB | PPCB |
|---|---|---|
| Price | $2.64 | $2.11 |
| Market cap | $2.1M | $20.7M |
| Today | +2.72% | 0.00% |
| 1 month | −25.4% | −57.3% |
| 6 months | −89.3% | −91.7% |
| Year to date | −99.3% | −98.4% |
| 1 year | −99.8% | −99.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | 29.5% | — |
| Net margin | −225.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.8× | — |
| Net cash | $9.4M | $832.0K |
| Dividend yield | — | — |
| Volatility (60d) | 676.5% | 730.6% |
| Short % of float | 0.4% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).